Pneumoconiosis Treatment Guidelines

Pneumoconiosis Treatment Guidelines

The specific guidelines for pneumoconiosis treatment vary from patient to patient. Generally speaking, treatment focuses on managing symptoms, preserving lung function and improving quality of life, since there is not presently a cure for pneumoconiosis.

Pneumoconiosis is an occupational lung disease that develops as a result of frequent, prolonged exposure to and inhalation of irritants like coal dust, silica and iron particles. Black lung disease (coal worker’s pneumoconiosis), silicosis and siderosis (welder’s lung) are the main forms of pneumoconiosis. Treatment guidelines for patients with these conditions often include:

  • Supplemental oxygen therapy – When the lungs alone aren’t able to supply an adequate amount of oxygen, receiving supplemental liquid oxygen or compressed oxygen gas through a face mask or nasal prongs can improve breathing and ease symptoms.
  • Bronchodilators – These medicines are used to help open up lung passages and improve breathing.
  • Not smoking – Smoking and other forms of tobacco use can exacerbate pneumoconiosis and cause additional health problems.
  • Avoiding exposure to harmful dusts and particles – It is important to avoid the substance that has led to pneumoconiosis, as continued exposure can worsen the disease and its symptoms.

The Lung Institute – the first stem cell therapy center in the world to focus exclusively on pulmonary disease – offers autologous stem cell treatment as an alternative form of care for pneumoconiosis patients. This innovative therapy has the potential to reduce symptoms, ease lung inflammation and slow the progression of pneumoconiosis. Stem cell treatment leverages the natural healing abilities of the patient’s own stem cells to help enhance lung function and improve quality of life.

Contact the Lung Institute at (800) 729-3065 to learn more about our innovative treatment guidelines for pneumoconiosis and other forms of interstitial lung disease. A member of our medical team can answer any questions you may have about stem cell therapy and help determine if you are a potential candidate for treatment at the Lung Institute.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.